Database for understanding diabetes complications
Official title: Tübinger Diabetes Mellitus Database (TUEDID)
Run by University Hospital Tuebingen · NCT03658512 · Data updated 2026-11-12
This study is collecting information from adults with diabetes to see what factors might predict complications like nerve damage and eye problems, with the goal of improving patient care and quality of life.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 85 Years |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | University Hospital Tuebingen Academic / other |
| Locations | 1 site (Tübingen) |
| Status | Recruiting |
| Started | February 5, 2018 |
| Main results expected | February 1, 2035 |
| Study ends | February 1, 2035 |
| Registry record updated | July 9, 2026 |
| Trial ID | NCT03658512 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals over 18 years old diagnosed with diabetes mellitus.
✕Probably not a fit
Patients who are unable to provide written informed consent will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The Tübinger Diabetes Mellitus Database (TUEDID) aims to collect and analyze data from diabetic patients to identify predictive parameters for the progression of diabetes and its associated complications. This observational study will focus on characterizing patients over 18 years old to enhance risk assessment tools for late complications such as neuropathy, retinopathy, and cardiovascular issues. By gathering comprehensive data, the study seeks to improve patient quality of life and inform health economic strategies related to diabetes management.
Why it matters
Potential benefit: If successful, this study could lead to better predictive tools for managing diabetes complications, ultimately improving patient outcomes.
How similar studies have gone: Other studies have explored diabetes complications, but the specific approach of this database is novel in its focus on predictive parameters.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * \>18 years Exclusion Criteria: * no written informed consent
Where it's running
-
University of Tuebingen, Internal medicine IV
Tübingen, Germany Recruiting
Study contacts
- Study coordinator: Andreas Fritsche, MD
- Email: andreas.fritsche@med.uni-tuebingen.de
- Phone: +49 7071 29 80687
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Preventing lower limb artery disease in adults with diabetes using a risk-prediction model and HAPA-based nursing
A risk-prediction model is tested in adults with type 2 diabetes to see if a nursing plan based on the HAPA model can reduce peripheral artery disease in the legs.
-
DiaFootCare: a mobile app to help adults with diabetic foot ulcers manage self-care in Oman
A mobile app called DiaFootCare will be tested to see if it helps adults with diabetic foot ulcers in Oman take better care of themselves and improve healing compared with usual care.
-
Predictive CGM with App for people with type 1 or insulin-treated type 2 diabetes
This study tests whether using the Accu-Chek SmartGuide CGM with its Predict App can reduce fear of hypoglycemia and improve related behaviors and confidence in adults with type 1 or insulin-treated type 2 diabetes.
-
SugarVita 2.0: a 12-week digital game for adults with type 2 diabetes
This 12-week pilot tests SugarVita 2.0, a serious digital game, to see if it helps adults with type 2 diabetes manage their condition and feel more confident.
-
Linking social care with healthcare to help manage chronic diseases
This trial tests whether pairing patients with trained community health workers can help them get transportation, healthy food, information, and better access to care to improve health in conditions like hypertension, diabetes, and high cholesterol.
-
Transcutaneous and topical photobiomodulation for diabetic foot ulcers
This phase 2 trial tests whether combining transcutaneous and topical photobiomodulation helps heal foot ulcers in adults with diabetes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.